DOT1L antisense RNA 1 (DOT1L-AS1)

DOT1L antisense RNA 1 (DOT1L-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand at the DOT1L locus. Unlike the protein DOT1L (disruptor of telomeric silencing 1-like), DOT1L-AS1 is not an enzyme, receptor, or typical druggable target. The current literature and databases provide limited detailed functional characterization of DOT1L-AS1 itself. Its designation suggests that it may regulate its sense gene (DOT1L) via antisense-mediated mechanisms such as RNA interference, chromatin modification, or transcriptional interference, but this is not established in the provided sources. There is substantial research relating to the protein DOT1L, a histone methyltransferase implicated in gene regulation, cell cycle control, development, and certain cancers, with small molecule inhibitors in clinical development. However, DOT1L-AS1 refers specifically to the non-coding RNA, and there is currently no evidence that it functions as a direct therapeutic target, interacts with drugs, or is used as a biomarker. If you require information about the protein DOT1L, rather than the lncRNA DOT1L-AS1, please clarify, as the protein is a well-established therapeutic target, whereas the lncRNA is not.

Other names

DOT1L-AS1